What are the oncologic outcomes of LMIC-specific guidelines for cancer treatment?
What is the value of screening high-risk patients, as opposed to average risk patients, in LMIC?
Are there new technologies that can be used in low resource areas that are : point of care, cost effective, durable, low maintenance?
Which high-income country cancer diagnostics are useful for cancer screening in LMIC?
How do cancer mutation analyses fit into LMIC cancer diagnosis and treatments?
What is the role for minimally invasive cancer surgery techniques in LMIC?
|